Skip to main content
Premium Trial:

Request an Annual Quote

OGeS to Develop Colorectal Cancer Biomarkers With Oxford University Researchers, Joins GE Consortium

NEW YORK, April 12 (GenomeWeb News) - Oxford Genome Sciences and researchers at the Department of Clinical Pharmacology of the University of Oxford are collaborating to discover clinical biomarkers for colorectal cancer, OGeS said today.

 

In forming the collaboration, OGeS joins an ongoing research consortium between the University of Oxford and GE Healthcare to develop personalized diagnostic tests and treatments for colorectal cancer. The consortium was founded last fall with funding from GE Healthcare.

 

Under the two-year agreement, OGeS will use its proteomics technology and Oxford Genome Anatomy Project protein database to discover diagnostics for early- and late-stage colorectal cancer, and to identify protein biomarkers of recurring colorectal cancer. OGeS will analyze protein profiles of blood samples, as well as genetic variations and risk factors, from colorectal cancer patients.

 

Last week, OGeS and Biosite said they were also collaborating to develop new diagnostics for relapsing colorectal cancer.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.